ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CEL Celadon Pharmaceuticals Plc

107.50
12.50 (13.16%)
15 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 13.16% 107.50 105.00 110.00 107.50 95.00 95.00 147,026 15:40:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 24k -17.01M -0.2722 -3.95 67.16M

Mytrah Energy Ltd Director Share Dealing (8038C)

20/10/2015 10:24am

UK Regulatory


Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Celadon Pharmaceuticals Charts.

TIDMMYT

RNS Number : 8038C

Mytrah Energy Ltd

20 October 2015

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

20 October 2015

Mytrah Energy Limited

('Mytrah' or 'the Company')

Director Share Dealing

The Company was informed on 19 October 2015, that on the same day R&H Trust Co (Jersey) Limited (the "Trustee") as trustee of The Raksha Trust (the "Trust"), a Jersey based discretionary trust settled by Ravi Kailas, the Chairman and CEO of Mytrah, of which he and some of his family members and also a philanthropic trust are discretionary beneficiaries, purchased 436,530 Ordinary Shares in Mytrah at 59.88p per Ordinary Share.

Following this purchase, the Trustee has an interest in 94,751,030 Ordinary Shares representing, in aggregate, approximately 57.90% of the issued share capital of the Company for a beneficial class comprising Ravi Kailas, some of his family members and a philanthropic trust.

For further information please visit www.mytrah.com or contact:

 
 Mytrah Energy Limited                  +44 (0)20 3402 
  Ravi Kailas / Bob Smith                5790 
 Investec Bank plc                      +44 (0)20 7597 
  Chris Sim / Jeremy Ellis               5970 
 
 Mirabaud Securities LLP                  +44 (0)20 7878 
  Peter Krens / Rory Scott                3360 
 
 Yellow Jersey PR Limited                 +44 (0)77 4778 
  Charles Goodwin / Dominic Barretto      8221 
 

About Mytrah Energy Ltd. Mytrah Energy Ltd. (AIM: MYT), the pioneer and one of the largest Independent Power Producers ('IPP') in renewable energy, in India, with 560 MW of wind power generation across 11 projects and 6 States. The Company has 172 wind masts installed across multiple states in India, providing a rich source of information from which to select its future projects. Mytrah currently has an active development pipeline of about 3500 MW of wind and 500 MW of solar.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEANEEAAESFEF

(END) Dow Jones Newswires

October 20, 2015 05:24 ET (09:24 GMT)

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock